GNOM Global X Genomics & Biotechnology ETF Loading...

Loading chart...
Top Calls
Feed
Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
16:39
Jul 01
incomesharks
Buy $GNOM on the thesis that AI unlocks genomics breakthroughs, with a catalyst from a major disease‑cure news story, supported by recent 20% momentum.
GNOM
MED
22:42
Jun 27
incomesharks
Buy genomics ETF as part of healthcare/biotech midterm H2 seasonal rotation; lowest-conviction leg given GNOM's thin liquidity relative to XBI/ARKG.
GNOM
MED
17:15
Jun 23
CryptoCondom
Author prefers single tickers over ETFs like GNOM or ARKG for broad exposure, offering no directional view.
GNOM
LOW
14:19
Jun 23
incomesharks
Long GNOM based on near all-time lows and forward-looking outperformance potential vs other ETFs near highs.
GNOM
MED
20:44
Jun 22
incomesharks
Buy GNOM for long-term outperformance as AI makes genome stocks sensible, with the ETF near ATLs offering upside vs S&P near ATHs.
GNOM
HIGH
06:01
Jun 18
incomesharks
GNOM has explicit 100 price target from current 50 level.
Author states GNOM is at 50 with a 100 target, which is an explicit forward bullish price-target call.
GNOM 1ST

About GNOM Analyst Coverage

Buzzberg tracks GNOM (Global X Genomics & Biotechnology ETF) across 2 sources. 5 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (83%). 6 total trade ideas tracked. Latest voices: incomesharks, CryptoCondom.